Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Gutwein P et al. – The authors data demonstrate that ADAM10 and L1–CAM have important roles during melanoma progression and both molecules represent attractive targets for therapeutical intervention of melanomas.

Related Articles

Loss of SNF5 expression correlates with poor patient survival in melanoma
Clinical Cancer Research, 10/12/09    Relevance Score: 97%

Slow-growing melanoma: a dermoscopy follow-up study
British Journal of Dermatology, 10/05/09    Relevance Score: 93%

Dormancy of metastatic melanoma
Pigment Cell & Melanoma Research, 11/11/09    Relevance Score: 91%

Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression
Modern Pathology, 11/11/09    Relevance Score: 90%

KIT as a Therapeutic Target in Melanoma
Journal of Investigative Dermatology, 10/23/09    Relevance Score: 90%

Today in Dermatology...keeping you current

Familial atypical cold urticaria: Description of a new hereditary disease
Journal of Allergy and Clinical Immunology, 11/25/09

Schnitzlers syndrome with prominent neutrophil infiltration misdiagnosed as Sweets syndrome: a typical example of urticarial neutrophilic dermatosis
Clinical and Experimental Dermatology, 11/25/09

Failure of omalizumab in cholinergic urticaria
Clinical and Experimental Dermatology, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address